After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Knowing where to invest for retirement in your 40s is essential. Uncover top investment opportunities that align with your goals.
17,250 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Private SpaceX uses extended lockups for insiders, signaling a disciplined cash strategy. This article breaks down wh...
Credo Technology Group has surged about 90% year-to-date, fueling debate on whether the rally can sustain amid new AI...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Marcus Goldman Sachs Savings offers a no-fee, no-minimum online savings option with daily compounding. Here’s how it ...
Rivian just raised its vehicle guidance to 70,000 units while a company director sold shares. This article breaks dow...
As AI spending hits record levels, Chamath Palihapitiya argues the real test is whether buyers of AI can deliver dura...
The U.S. launched a new round of strikes against Iran, triggering swift market reactions and renewed concerns about a...
Refining margins surge, not crude prices, lifting major U.S. refiners and redefining the 2026 rally in energy stocks.
Boeing’s June performance marks more than a monthly milestone. With 64 jets delivered, the company nudges its cash fl...
A new plan to monetize Truth Social could let Wall Street traders see posts milliseconds before others. The move prom...
A congressional hearing places federal fraud losses close to $1 trillion annually, far surpassing GAO estimates, as e...